A coalition of pharmacy advocacy organizations, including ASCP, has been working to introduce legislation that would allow pharmacists to practice at the top of their license and bill Medicare Part B for their services. The Pharmacy and Medically Underserved Areas Enhancement Act, commonly referred to as “Provider Status”, would finally allow pharmacists to be reimbursed for the vital clinical services they provide to the community. The bill was previously introduced in the 114th and 115th Congresses and garnered widespread bipartisan support in both houses of Congress.
ASCP is a member of the Patient Access to Pharmacists' Care Coalition (PAPCC), which is a coalition of groups dedicated to passing provider status. The Coalition is currently working to introduce bipartisan legislation to combat the growing opioid crisis in this country. As you know, pharmacists can play an important role in this battle. Pharmacists can help fight against the opioid epidemic by managing and optimizing the impact of medications, reviewing medications to tailor care plans to patient needs, providing recommendations for non-opioid pain management alternatives, and educating patients regarding opioids. Additionally, as the most accessible member of the health care team, pharmacists can help coordinate care, provide treatment options and feedback to patients and other providers, and flag concerns with the appropriate members of the care team.
Now is the perfect time to remind members of Congress the important role that pharmacists can play in combating this crisis, if they were recognized under Medicare Part B as part of the health care team. Make plans to attend our annual Fly-In this Spring 2020 to storm the Hill and advocate for our profession!
The link to our one-pager about how Provider Status would positively impact older adult care can be found here.
ASCP is a member of the Patient Access to Pharmacists' Care Coalition (PAPCC), which is a coalition of groups dedicated to passing provider status.
ASCP has a Policy Statement on The Role of the Consultant Pharmacist in Preventing and Detecting Diversion of Controlled Substances in Nursing Facilities. (PDF)
ASCP joined with six other pharmacy associations in writing to the House Energy & Commerce Committee Hearing in October 2017, a Statement For The Record (PDF), asking them to consider the important role that pharmacists can play in addressing the opioid abuse crisis in this country.